Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Etidronate disodium [USAN:USP:JAN]
RN: 7414-83-7
UNII: M16PXG993G
InChIKey: GWBBVOVXJZATQQ-UHFFFAOYSA-L

Note

  • A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.

Molecular Formulas

  • C2-H6-Na2-O7-P2
  • C2-H6-O7-P2.2Na
  • C2-H8-O7-P2.2Na

Molecular Weight

  • 249.9904
 

Classification Codes

  • Bone Resorption Inhibitor
  • Drug / Therapeutic Agent
  • Human Data
  • Mutation Data
  • Reproductive Effect
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Etidronate disodium
  • Etidronate disodium [USAN:USP:JAN]

MeSH Heading

  • Etidronate disodium

Synonyms

  • (1-Hydroxyethane-1,1-diyl)diphosphonic acid disodium salt
  • (1-Hydroxyethylidene)diphosphonic acid, disodium salt
  • 1-Hydroxyethylidene-1,1-diphosphonic acid disodium salt
  • Didronel
  • Didronel R
  • Diphos
  • Disodium (1-hydroxyethylidene)diphosphonate
  • Disodium 1-hydroxyethylidene phosphonate
  • Disodium dihydrogen (1-hydroxyethylidene)diphosphonate
  • Disodium ethane-1-hydroxy-1,1-diphosphonate
  • Disodium ethanol-1,1-diphosphonate
  • Disodium ethydronate
  • Disodium etidronate
  • EINECS 231-025-7
  • Ethane-1-hydroxy-1,1-diphosphonate, disodium salt
  • Ethane-1-hydroxy-1,1-diphosphonic acid, disodium salt
  • Etidronate disodium
  • Etidronsaeure dinatriumsalz
  • NSC 759157
  • SM-5600
  • Sodium ethidronate
  • Sodium ethydronate
  • Sodium etidronate
  • UNII-M16PXG993G

Systematic Names

  • Disodium dihydrogen (1-hydroxyethylidene)bisphosphonate
  • Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt
  • Phosphonic acid, (1-hydroxyethylidene)di-, disodium salt
  • Phosphonic acid, P,P'-(1-hydroxyethylidene)bis-, sodium salt (1:2)

Registry Numbers

CAS Registry Number

  • 7414-83-7

FDA UNII

  • M16PXG993G

Other Registry Numbers

  • 1159812-97-1
  • 1338481-55-2
  • 187285-10-5

System Generated Number

  • 0007414837

Molecular Formulas

Molecular Formulas

  • C2-H6-Na2-O7-P2
  • C2-H6-O7-P2.2Na
  • C2-H8-O7-P2.2Na

Molecular Formula Fragments

  • C2-H6-O7-P2
  • C2-H8-O7-P2
  • COMPONENT
  • Na

Structure Descriptors

InChI

InChI=1S/C2H8O7P2.2Na/c1-2(3,10(4,5)6)11(7,8)9;;/h3H,1H3,(H2,4,5,6)(H2,7,8,9);;/q;2*+1/p-2

InChIKey

GWBBVOVXJZATQQ-UHFFFAOYSA-L

Smiles

[Na+].[Na+].CC(O)(P(=O)(O)[O-])P(=O)(O)[O-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous 32mg/kg (32mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)		 Journal of Pharmaceutical Sciences. Vol. 73, Pg. 1097, 1984.
dog LDLo oral 500mg/kg (500mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: ATAXIA

SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE		 Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 1257, 1989.
mouse LD50 intraperitoneal 250mg/kg (250mg/kg)   British UK Patent Application. Vol. #2096889,
mouse LD50 intravenous 49mg/kg (49mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 1251, 1989.
mouse LD50 oral 1900mg/kg (1900mg/kg)   Drugs in Japan Vol. -, Pg. 221, 1995.
mouse LD50 subcutaneous 260mg/kg (260mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 1251, 1989.
rabbit LD50 oral 581mg/kg (581mg/kg) KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITIS

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"		 Toxicology and Applied Pharmacology. Vol. 22, Pg. 661, 1972.
rat LD50 intravenous 35mg/kg (35mg/kg)   British UK Patent Application. Vol. #2096889,
rat LD50 oral 1340mg/kg (1340mg/kg) KIDNEY, URETER, AND BLADDER: CHANGES IN BOTH TUBULES AND GLOMERULI Toxicology and Applied Pharmacology. Vol. 22, Pg. 661, 1972.
rat LD50 subcutaneous 372mg/kg (372mg/kg) SENSE ORGANS AND SPECIAL SENSES: CHROMODACYRORREA: EYE

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)		 Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 1251, 1989.
women TDLo oral 240mg/kg/26W- (240mg/kg) SENSE ORGANS AND SPECIAL SENSES: CHANGE IN ACUITY: EAR

SENSE ORGANS AND SPECIAL SENSES: TINNITUS: EAR		 Postgraduate Medical Journal. Vol. 74, Pg. 363, 1998.
women TDLo oral 240mg/kg/22W- (240mg/kg) SENSE ORGANS AND SPECIAL SENSES: CHANGE IN ACUITY: EAR

SENSE ORGANS AND SPECIAL SENSES: TINNITUS: EAR		 Postgraduate Medical Journal. Vol. 74, Pg. 363, 1998.
women TDLo oral 588mg/kg/28W- (588mg/kg) MUSCULOSKELETAL: OTHER CHANGES

MUSCULOSKELETAL: OSTEOMALACIA		 Drug Safety. Vol. 7, Pg. 162, 1992.